ADIPOQ and type 2 diabetes mellitus: As our recent Mendelian randomization collaborative study indicated, by using an ADIPOQ genetic summary risk score, no evidence of an association between adiponectin-lowering alleles and insulin sensitivity or type 2 diabetes appears present (Yaghootkar et al., 2013).